Nuclear respiratory factor-1 and bioenergetics in tamoxifen-resistant breast cancer cells

Acquired tamoxifen (TAM) resistance is a significant clinical problem in treating patients with estrogen receptor α (ERα) + breast cancer. We reported that ERα increases nuclear respiratory factor-1 (NRF-1), which regulates nuclear-encoded mitochondrial gene transcription, in MCF-7 breast cancer cel...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Exp Cell Res
Autores principales: Radde, Brandie N., Ivanova, Margarita M., Mai, Huy Xuan, Alizadeh-Rad, Negin, Piell, Kellianne, Van Hoose, Patrick, Cole, Marsha P., Muluhngwi, Penn, Kalbfleisch, Ted S., Rouchka, Eric C., Hill, Bradford G., Klinge, Carolyn M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5011039/
https://ncbi.nlm.nih.gov/pubmed/27515002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yexcr.2016.08.006
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares